Glomerulosclerosis: Intrinsic and extrinsic pathways

Nephrology Dialysis Transplantation

Volumn 11, Issue 5, 1996, Pages 773-777

  El Nahas, A M ^a,b  

^a Sheffield Kidney Institute   (United Kingdom)

^b NORTHERN GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DECORIN; GAMMA INTERFERON; NEUTRALIZING ANTIBODY;

CHRONIC KIDNEY FAILURE; FIBROBLAST; GLOMERULOSCLEROSIS; HUMAN; KIDNEY FUNCTION; KIDNEY INTERSTITIUM; KIDNEY SCAR; MYOFIBROBLAST; PRIORITY JOURNAL; SHORT SURVEY;

EID: 0029979692     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.ndt.a027397     Document Type: Short Survey

References (51)

1. El Nahas AM. Glomerulosclerosis: Insights into pathogenesis and treatment. Nephrol Dial Transplant 1989: 4: 843-853
2. Bohle A, Mackensen-Haen S, Gise HV. Significance of tubulointerstitial changes in the renal cortex for the excretory function and concentration ability of the kidney. A morphometric contribution. Am J Nephrol 1987: 7: 421-443
3. Johnson RJ. The glomerular response to injury: Progression or resolution? Kidney Int 1994; 45: 11769-1782
4. El Nahas AM. Glomerulosclerosis: a form of atherosclerosis. In Nephrology, Proc Xih Int Congr Nephrol 1988; 11: 1206-1220
5. Diamond JR. Karnovsky MJ. Focal and segmental glomerulosclerosis: Analogies to atherosclerosis. Kidney Int 1988; 33: 917-924
6. Johnson RJ, Floege J, Couser WG, Alpers CE. Role of plateletderived growth factor in glomerular disease. J Am Soc Nephrol 1993; 4: 119-128
7. Border WA, Noble NA. Cytokines in kidney disease: The role of transforming growth factor-β. Am J Kidney Dis 11993; 22: 105-113
8. Isaka Y, Fujiwara Y, Ueda N, Kaneda Y, Kamada T, Imai E. Glomerulosclerosis induced by in vivo transfection of TGF-β or PDGF gene into the rat kidney. J Clin Invest 1993; 92: 2597-2601
9. Imai E, Arai M, Wada A, Suguira T et al. Phenotypic changes of the mesangial cells induced by overexpression of the TGF-β gene in in vivo glomeruli. J Am Soc Nephrol 1994; 5: 782
10. Johnson RJ, Iida H, Alpers CE et al. Expression of smooth muscle phenotype by rat mesangial cells in immune complex nephritis. J Clin Invest 1991; 87: 847-858
11. Alpers CE, Hudkins KL, Gown AM, Johnson RJ. Enhanced expression of 'muscle specific' actin in glomerulonephritis. Kidney Int 1992; 41: 1134-1142
12. MacPherson BR, Leslie KO, Lizaso KV, Schwartz JE. Contractile cells of the kidney in primary glomerular disorders: An immunohistochemical study using an anti-alpha-smooth muscle actin monoclonal antibody. Hum Pathol 1993; 24: 710-716
13. Goumenos D, Shortland J, Brown CB, El Nahas AM. Myofibroblasts: Predictors of progression of IgA nephropathy. Nephrol Dial Transplant 1994; 9: 1418-1425
14. Yaoita E, Kawasaki K, Yamamoto T, Kihara I. Variable expression of desmin in rat glomerular epithelial cells. Am J Pathol 1990; 136: 899-908
15. Muchaneta-Kubara EC, El Nahas AM. Transdifferentiation of renal cells during experimental renal scarring. J Am Soc Nephrol 1995; 6: 903
16. Hugo HC, Pichler R, Gordon K et al. Moesin and radixin: cytoskeletal proteins associated with mesangial cell activation and migration in vitro and in disease. J Am Soc Nephrol 1994; 5: 782
17. Ohba S, Hiroi J. Kimura K et al. The expression of non-muscle type myosin heavy chain isoform, SMemb, in glomerular cells of remnant kidney. J Am Soc Nephrol 1994, 5: 790
18. Mise N. Hiroi J, Kimura K et al. Expression of non-muscle type myosin heavy chain isoform, Smemb, in glomerular cells of rat anti-glomerular baement membrane (GBM) nephritis. J Am Soc Nephrol 1994; 5: 788
19. Alpers CE, Seifert RA, Hudkins KL, Johnson RJ, Bowen-Pope DF. Developmental patterns of PDGF B-chain, PDGF-receptor. and α-actin expression in human glomerulogenesis. Kidney Int 1992; 42. 390-399
20. Floege J, Johnson RJ, Gordon K, et al. Increased synthesis of extracellular matrix in mesangial proliferative nephritis. Kidney Int 1991; 40: 477-488
21. Floege J, Alpers CE, Burns MW, et al. Glomerular cells, extracellular matrix accumulation, and the development of glomerulosclerosis in the remnant kidney model. Lab Invest 1992; 66: 485-497
22. Baker AJ, Mooney A, Lombardi D, Johnson RJ, Savill J. Mesangial cell apoptosis: The major mechanism for resolution of glomerular hypercellularity in experimental proliferative nephritis. J Clin Invest 1994; 94: 2105-2116
23. Costigan M, Chambers DA, Boot-Handford RP. Collagen turnover in renal disease. Exp Nephrol 1995; 3. 114-121
24. Okuda S, Languino LR. Ruoslahti E, Border WA. Elevated expression of transforming growth factor-β and proteoglycan production in experimental glomerulonephritis. Possible role in expansion of the mesangial extracellular matrix. J Clin Invest 1990; 86: 453-462
25. Yamamoto T, Noble NA, Miller DE, Border WA. Sustained expression of TGF-β underlies the development of progressive kidney fibrosis. Kidney Int 1994; 45: 916-927
26. Anderson S, Diamond JR, Karnovsky MJ, Brenner BM. Mechanisms underlying the transition from acute glomerular injury to late glomerular sclerosis in a rat model of nephrotic syndrome. J Clin Invest 1988; 82: 1757-1768
27. Bertani T. Cutillo F, Zoja C, Broggini M. Remuzzi G. Tubulointerstitial lesions mediate renal damage in adriamycin nephropathy. Kidney Int 1986; 30: 488-496
28. Alfrey AC, Froment DH, Hammond WS. Role of iron in the tubulo-interstitial injury in nephrotoxic serum nephritis. Kidney Int 1989; 36: 753-759
29. Alexopoulos E, Seron D, Hartley RB. Nolasco F, Cameron JS. Immune mechanisms in idiopathic membranous nephropathy: the role of interstitial infiltrates. Am J Kidney Dis 1989; 13: 404-412
30. Kuncio GS, Neilson EG, Haverty T. Mechanisms of tubulointerstitial fibrosis. Kidney Int 1991; 39: 550-556
31. Desmouliere A, Geinoz A, Gabbiani F, Gabbiani G. Transforming growth factor-β1 induces α-smooth muscle actin expression in granulation tissue myofibroblasts and in quiescent and growing cultured flbroblasts. J Cell Biol 1993; 122: 103-111
32. Sappino AP, Schurch W, Gabbiani G. Differentiation repertoire of fibroblastic cells: Expression of cytoskeletal proteins as marker of phenotypic modulation. Lab Invest 1990; 63: 144-161
33. Desmouliere A, Gabbiani G. Modulation of fibroblastic cytoskeletal features during pathological situations: The role of extracellular matrix. Cell Motil Cytoskeleton 1994; 29: 195-203
34. Alpers CE, Hudkins KL, Floege J, Johnson RJ. Human renal cortical interstitial cells with some features of smooth muscle cells participate in tubulo-interstitial and glomerular injury. J Am Soc Nephrol 1994; 5: 201-210
35. Strutz F, Caron R, Tomaszewski et al. Transdifferentiation: A new concept in renal fibrogenesis. J Am Soc Nephrol 1994; 5: 819
36. Edelman ER, Nugent MA, Smith LT, Karnovsky MJ. Basic fibroblast growth factor enhances the coupling of intimal proliferation and vasa vasorum in injured rat arteries. J Clin Invest 1992; 89: 465-473
37. Muchaneta-Kubara EC, Sayed-Ahmed N, El Nahas AM. Subtotal nephrectomy: A mosaic of growth factors. Nephrol Dial Transplant 1995; 10: 320-326
38. Bohle A, Strutz F, Muller GA. On the pathogenesis of chronic renal failure in primary glomemlopathies: A view from the interstitium. Exp Nephrol 1995; 2: 205-210
39. Bohle A, Gise HV, Mackensen-Haen S, Stark-Jakob B. The obliteration of postglomerular capillaries and its influence upon the function of both glomeruli and tubuli. Klin Wochenschift 1981, 59: 1043-1051
40. Fine LG, Norman J. Renal growth responses to acute and chronic injury: Routes to therapeutic intervention. J Am Soc Nephrol 1992; 2: S206-S211
41. Lan HY, Nikolic-Paterson DJ, Atkins RC. Involvement of activated periglomerular leucocytes in the rupture of Bowman's capsule and crescent progression in experimental glomerulonephritis. Lab Invest 1992; 67: 743-751
42. Wiggins RC, Goyal M, Merritt SE, Killen PD Vascular adventitial cell expression of collagen I messenger ribonucleic acid in anti-glomerular basement membrane antibody-induced crescentic nephritis in the rabbit. A cellular source for interstitial collagen in inflammatory renal disease. Lab Invest 1993; 68: 557-565
43. Striker L M-M, Killen PD. Chi E, Striker GE. The composition of glomerulosclerosis: 1. Studies in focal sclerosis crescentic glomerulonephritis and membranoproliferative glomerulonephritis. Lab Invest 1984; 51: 181-192
44. Zhang G, Moorhead PJ, El Nahas AM. Myofibroblasts and the progression of experimental glomerulonephrilis. Exp Nephrol 1995; 3: 308-318
45. Johnson RJ, Raines EW, Floege J et al. Inhibition of mesangial cell proliferation and matrix expansion in glomerulonephritis by an antibody to platelet-derived growth factor. J Exp Med 1992; 175: 1413-1416
46. Border WA, Okuda S, Languino LR, Sporn MB, Ruoslahti E Suppression of experimental glomerulonephritis by antiserum against transforming growth factor-β1. Nature 1990; 346: 371-374
47. Border WA, Noble NA, Yamamoto T et al. Natural inhibitor of transforming growth factor-β protects against scarring in experimental kidney disease. Nature 1992; 360: 361-364
48. Pittet B, Rubbia-Brandt L, Desmouliere A et al. Action of γ-interferon on the clinical and biologic evolution of hypertrophic scars and Dupuytren's disease: An open pilot study. Plast Reconstr Surg 1994; 93: 1224-1235
49. Johnson RJ. Lombardi D, Eng E, Gordon K, Alpers CE, Protzl P, Floege J. Young B, Pippin J, Couser WG, Gabbiani G, Modulation of experimental mesangial proliferative nephritis by interferon-γ. Kidney Int 1995; 47: 62-69
50. Floege J, Eng E, Young BA, Couser WG, Johnson RJ. Heparin suppresses mesangial cell proliferation and matrix expansion in experimental membranoproliferative glomerulonephritis. Kidney Int 1993; 43: 369-380
51. Desmouliere A, Retard M, Darby I, Gabbiani G. Apoptosis mediates the decrease in cellularity during the transition between granulation tissue and scar. Am J Pathol 1995; 146: 56-66